Table 4.
Subgroup analyses
Variable | Development of mental illness, n (%) | Multivariable model, odds ratio (95% CI) | P |
---|---|---|---|
Male (n = 140 391) | |||
Control | 9656/137 977 (7.0) | 1 | |
COVID-19 survivors | 265/2414 (11.0) | 1.67 (1.45–1.92) | <0.001 |
Female (n = 120 492) | |||
Control | 9868/116 758 (8.5) | 1 | |
COVID-19 survivors | 473/3734 (12.7) | 2.06 (1.87–2.27) | <0.001 |
Age: 20–39 (n = 109 567) | |||
Control | 6948/106 903 (6.5) | 1 | |
COVID-19 survivors | 213/2664 (8.0) | 1.60 (1.36–1.89) | <0.001 |
Age: 40–59 (n = 84 723) | |||
Control | 5782/82 600 (7.0) | 1 | |
COVID-19 survivors | 301/2123 (14.2) | 2.27 (1.99–2.58) | <0.001 |
Age: ≥60 (n = 66 593) | |||
Control | 6794/65 232 (10.4) | 1 | |
COVID-19 survivors | 224/1361 (16.5) | 1.86 (1.63–2.13) | <0.001 |
Charlson Comorbidity Index: 0–2 (n = 158 863) | |||
Control | 11 569/156 343 (7.4) | 1 | |
COVID-19 survivors | 322/2520 (12.8) | 1.93 (1.72–2.15) | <0.001 |
Charlson Comorbidity Index: ≥3 (n = 102 020) | |||
Control | 7955/98 392 (8.1) | 1 | |
COVID-19 survivors | 416/3628 (11.5) | 1.93 (1.71–2.17) | <0.001 |
COVID-19, coronavirus disease 2019.